Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -21.36% is 13% above its 5-year average of -24.64%, around the middle of its 5-year range (-85.01%–11.78%).
As of the fiscal period ended Tuesday, June 30, 2026. 65.14% above its 12-month average of -61.26%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -21.36%.
RETURN ON INVESTED CAPITAL (ROIC)
-21.36%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-61.26%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-27.91%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-24.64%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-28.49%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+65.14%
CURRENT VS 3Y AVG
+23.49%
CURRENT VS 5Y AVG
+13.33%
CURRENT VS 10Y AVG
+25.04%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
+40.09%
vs the sector median at left
Prothena Corporation plc
Market Cap
$421.97M
Return on Invested Capital (ROIC)
-21.36%
TTM Avg
-61.26%
3Y Avg
-27.91%
5Y Avg
-24.64%
Market Cap
$424.78M
Return on Invested Capital (ROIC)
-114.65%
TTM Avg
-31.55%
3Y Avg
-26.30%
5Y Avg
-23.63%
Market Cap
$416.06M
Return on Invested Capital (ROIC)
-71.22%
TTM Avg
-79.15%
3Y Avg
-65.81%
5Y Avg
-107.73%
Market Cap
$426.64M
Return on Invested Capital (ROIC)
-2.98%
TTM Avg
-62.76%
3Y Avg
-40.63%
5Y Avg
-28.06%
Market Cap
$430.46M
Return on Invested Capital (ROIC)
-48.61%
TTM Avg
-80.33%
3Y Avg
-62.04%
5Y Avg
-50.84%
Market Cap
$413.97M
Return on Invested Capital (ROIC)
-69.35%
TTM Avg
-52.27%
3Y Avg
-73.46%
5Y Avg
-73.46%
Market Cap
$412.30M
Return on Invested Capital (ROIC)
-7.11%
TTM Avg
-10.90%
3Y Avg
-16.50%
5Y Avg
-14.69%
Market Cap
$431.42M
Return on Invested Capital (ROIC)
-5.29%
TTM Avg
-5.58%
3Y Avg
-6.88%
5Y Avg
-5.95%
Market Cap
$410.38M
Return on Invested Capital (ROIC)
-19.13%
TTM Avg
-11.02%
3Y Avg
-12.07%
5Y Avg
-13.96%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Prothena Corporation plc (PRTA) | $421.97M | -21.36% | -61.26% | -27.91% | -24.64% |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $424.78M | -114.65% | -31.55% | -26.30% | -23.63% |
| Senseonics Holdings, Inc. (SENS)vs › | $416.06M | -71.22% | -79.15% | -65.81% | -107.73% |
| Tilray Brands, Inc. (TLRY)vs › | $426.64M | -2.98% | -62.76% | -40.63% | -28.06% |
| Editas Medicine, Inc. (EDIT)vs › | $430.46M | -48.61% | -80.33% | -62.04% | -50.84% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $413.97M | -69.35% | -52.27% | -73.46% | -73.46% |
| Strata Critical Medical, Inc. (SRTA)vs › | $412.30M | -7.11% | -10.90% | -16.50% | -14.69% |
| NeoGenomics, Inc. (NEO)vs › | $431.42M | -5.29% | -5.58% | -6.88% | -5.95% |
| Myriad Genetics, Inc. (MYGN)vs › | $410.38M | -19.13% | -11.02% | -12.07% | -13.96% |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $410.19M | -46.16% | -62.80% | -62.80% | -62.80% |
ROIC
-21.4%
ROE
-15.3%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -21.36% |
| 2026-03-31 | -39.79% |
| 2025-12-31 | -75.35% |
| 2025-09-30 | -84.77% |
| 2025-06-30 | -85.01% |
| 2025-03-31 | -31.02% |
| 2024-12-31 | -31.00% |
| 2024-09-30 | -30.64% |
| 2024-06-30 | -15.26% |
| 2024-03-31 | -37.29% |
| 2023-12-31 | -29.87% |
| 2023-09-30 | -16.23% |
| 2023-06-30 | -26.69% |
| 2023-03-31 | -21.65% |
| 2022-12-31 | -18.58% |
| 2022-09-30 | -32.66% |
| 2022-06-30 | -0.54% |
| 2022-03-31 | 11.78% |
| 2021-12-31 | 11.62% |
| 2021-09-30 | 11.51% |
| 2021-06-30 | -17.03% |
| 2021-03-31 | -33.68% |
| 2020-12-31 | -36.71% |
| 2020-09-30 | -31.64% |
| 2020-06-30 | -26.59% |
| 2020-03-31 | -22.91% |
| 2019-12-31 | -21.34% |
| 2019-09-30 | -20.32% |
| 2019-06-30 | -20.40% |
| 2019-03-31 | -29.94% |
| 2018-12-31 | -32.83% |
| 2018-09-30 | -36.61% |
| 2018-06-30 | -41.11% |
| 2018-03-31 | -29.36% |
| 2017-12-31 | -33.83% |
| 2017-09-30 | -31.54% |
| 2017-06-30 | -27.14% |
| 2017-03-31 | -30.71% |
| 2016-12-31 | -38.08% |
| 2016-09-30 | -30.38% |
| 2016-06-30 | -24.40% |
| 2016-03-31 | -19.72% |
| 2015-12-31 | -22.02% |
| 2015-09-30 | -18.10% |
| 2015-06-30 | -14.91% |
| 2015-03-31 | -14.18% |
| 2014-12-31 | -2.28% |
| 2014-09-30 | -1.40% |
| 2014-06-30 | -0.23% |
| 2014-03-31 | -6.90% |
| 2013-12-31 | -23.10% |
| 2013-09-30 | -41.85% |
| 2013-06-30 | -37.71% |
| 2013-03-31 | -33.20% |
| 2012-12-31 | -32.47% |
